Investment Analysts’ downgrades for Wednesday, October 11th:

Green Dot Corporation (NYSE:GDOT) was downgraded by analysts at Lake Street Capital from a buy rating to a hold rating. The firm currently has $55.00 price target on the stock, up from their previous price target of $44.00.

Granite Construction (NYSE:GVA) was downgraded by analysts at Seaport Global Securities from a buy rating to a neutral rating. They currently have $64.00 target price on the stock.

Imax Corporation (NYSE:IMAX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Shares of IMAX have underperformed its industry on a year-to-date basis due to multiple headwinds. The company has had a disappointing run at the box office over the past few months. Soft box-office revenues have been hurting the company significantly. Also, the substantial presence outside the United States exposes IMAX to foreign exchange related risks. High costs may hurt the bottom line in the third quarter of 2017.  The stock has witnessed the third-quarter Zacks Consensus Estimate for earnings being revised 45.5% downward over the last 90 days. Detailed results should be out on Oct 26. We are, however, impressed by the company's decision, announced earlier in 2017, pertaining to a new buyback program worth up to $200 million.”

Merck & (NYSE:MRK) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Merck’s new products like Keytruda and Zepatier should continue to contribute meaningfully to the top line. However, generic competition for several drugs will continue to be overhangs on the top line. Competitive and pricing pressures are also hurting sales of drugs like Isentress and Remicade. The diabetes franchise is also seeing slow sales since the past few quarters. Rising competition in the immuno-oncology market is also a significant concern. Meanwhile, Merck has also had its share of pipeline and regulatory setbacks. It recently dropped development of two of its HCV programs as the HCV market is becoming extremely crowded. Merck’s shares underperformed the industry this year so far. Estimates have remained stable ahead of the company’s Q3 earnings release. Merck has a positive record of earnings surprises in the recent quarters.”

Park-Ohio Holdings Corp. (NASDAQ:PKOH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Park Ohio Holdings Corp. operates through two segments, Manufactured Products and Logistics, which serve a wide variety of industrial markets. Manufactured Products designs and manufactures a broad range of high quality products engineered for specific customer applications. The principal customers of Manufactured Products are original equipment manufacturers and end-users in the automotive, railroad, truck and aerospace industries. Logistics is a leading national supplier of fasteners (e.g., nuts, bolts and screws) and other industrial products. “

Douglas Dynamics (NYSE:PLOW) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Douglas Dynamics, Inc. designs, manufactures and sells snow and ice control equipment for light trucks, which is comprised of snowplows and sand and salt spreaders, and related parts and accessories. The Company sells its products under the WESTERN(R), FISHER(R) and BLIZZARD(R) brands through a distributor network, primarily consisting of truck equipment distributors located throughout the Midwest, East and Northeast regions of the United States as well as all provinces of Canada. It sells its products primarily to professional snowplowers who are contracted to remove snow and ice from commercial, municipal and residential areas. Douglas Dynamics, Inc. is headquartered in Milwaukee, Wisconsin. “

Pinnacle Financial Partners (NASDAQ:PNFP) was downgraded by analysts at Zacks Investment Research from a buy rating to a sell rating. According to Zacks, “Pinnacle Financial Partners, Inc. is a bank holding company which owns 100% of the capital stock of Pinnacle National Bank, a national bank operating in the Nashville, Tennessee metropolitan area. “

Paratek Pharmaceuticals (NASDAQ:PRTK) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Paratek Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapeutics that treat infectious disease agents. The Company’s lead product candidate, omadacycline, is a tetracycline-derived antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. Its second product candidate, WC 3035 is a tetracycline-derived compound designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals, Inc., formerly known as Transcept Pharmaceuticals, Inc., is based in United States. “

PTC Therapeutics (NASDAQ:PTCT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States. “

Asante Solutions (NASDAQ:PUMP) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “ProPetro Holding Corp. provides oilfield services. It offers hydraulic fracturing and other complementary services to leading upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. ProPetro Holding Corp. is headquartered in Midland, Texas. “

Pzena Investment Management (NYSE:PZN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Pzena Investment Management, LLC, which will become the company’s operating company upon the consummation of the offering, is a premier value-oriented investment management firm with a record of investment excellence and exceptional client service. “

Ritchie Bros. Auctioneers (NYSE:RBA) (TSE:RBA) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Ritchie Bros. Auctioneers conduct unreserved public auctions every year at locations throughout North and Central America, Europe, Asia, Australia, Africa and the Middle East. The company is known for their innovative auction methods, attention to detail and their total commitment to the unreserved auction. The confidence this gives their customers has enabled Ritchie Bros. to become one of the largest industrial auctioneer in the world. “

Republic Bancorp (NASDAQ:RBCAA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Republic Bancorp, Inc. is a financial holding company. “

Real Industry (NASDAQ:RELY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Real Industry, Inc. is a holding company which invests in businesses primarily in the United States industrial and commercial marketplace. Real Industry Inc., formerly known as Signature Group Holdings, Inc., is based in Sherman Oaks, United States. “

Recro Pharma (NASDAQ:REPH) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-operative pain and cancer breakthrough pain; sublingual formulation of Dex for the treatment of chronic pain; and Fadolmidine (Fado), a product candidate to treat post-operative pain and neuropathic pain. Recro Pharma, Inc. is based in Malvern, Pennsylvania. “

Rex Energy Corporation (NASDAQ:REXX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Rex Energy Corporation is an independent oil and gas company operating in the Illinois Basin, the Appalachian Basin and the southwestern region of the United States. The Company pursues a balanced growth strategy of exploiting its sizable inventory of lower-risk developmental drilling locations, pursuing its higher-potential exploration drilling and enhanced oil recovery projects, and actively seeking to acquire complementary oil and natural gas properties. “

Repligen Corporation (NASDAQ:RGEN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are a leading manufacturer of Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. They also supply several growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, they have developed and marketed their OPUSĀ® series of pre-packed plug-and-play chromatography columns, and they provide test kits to ensure final product quality. Aside from their core bioprocessing business, they have a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and an orphan drug candidate in Phase 1 development. “

Tutor Perini Corporation (NYSE:TPC) was downgraded by analysts at Seaport Global Securities from a buy rating to a neutral rating. Seaport Global Securities currently has $31.00 target price on the stock.

Receive News & Ratings for Green Dot Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Dot Corporation and related companies with MarketBeat.com's FREE daily email newsletter.